Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 1/2020

11.10.2019 | Otology

Food-induced stimulation of the antisecretory factor to improve symptoms in Meniere’s disease: our results

verfasst von: Alfonso Scarpa, Massimo Ralli, Pasquale Viola, Claudia Cassandro, Matteo Alicandri-Ciufelli, Maurizio Iengo, Giuseppe Chiarella, Marco de Vincentiis, Michele Cavaliere, Ettore Cassandro

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Specially processed cereals (SPC) that increase endogenous antisecretory factor (AF) synthesis have been proposed to improve symptoms of Meniere’s disease (MD) with controversial results. The aim of this study was to evaluate the effects of SPC in patients with definite unilateral MD and compare the results to a treatment protocol with intravenous glycerol and dexamethasone.

Methods

Thirteen patients with unilateral MD were treated with SPC and 13 patients were treated with intravenous glycerol and dexamethasone for 12 months. Audio-vestibular evaluation was performed before (T0) and at the end of the treatments (T12). The number of vertigo spells were evaluated before and after therapy and the Efficacy Index (EI) was calculated. Questionnaires for hearing loss (HHIA), tinnitus (THI) and quality of life (TFL) were administered.

Results

EI decreased in the SPC group in the second semester compared to the first although not significantly (p = 0.6323). There was a significant reduction for THI score in the SPC group at T12 (p = 0.0325). No significant differences were found between the two groups at T0 (p = 0.4723), while a significant difference was found at T12 (p = 0.0041). Quality of life showed an improvement in daily activities in the SPC group compared to infusion therapy group.

Conclusion

Our study shows a reduced number of vertigo attacks and a positive effect on the discomfort generated by tinnitus and quality of life in patients with unilateral MD treated with SPC and when compared to patients treated with intravenous glycerol and dexamethasone. No effects on hearing thresholds were noted in both groups.
Literatur
4.
Zurück zum Zitat Paparella MM (1991) Methods of diagnosis and treatment of Meniere's disease. Acta Otolaryngol Suppl 485:108–119CrossRef Paparella MM (1991) Methods of diagnosis and treatment of Meniere's disease. Acta Otolaryngol Suppl 485:108–119CrossRef
8.
Zurück zum Zitat Hussain K, Murdin L, Schilder AG (2018) Restriction of salt, caffeine and alcohol intake for the treatment of Meniere's disease or syndrome. Cochrane Database Syst Rev 12:CD012173. 10.1002/14651858.CD012173.pub2 Hussain K, Murdin L, Schilder AG (2018) Restriction of salt, caffeine and alcohol intake for the treatment of Meniere's disease or syndrome. Cochrane Database Syst Rev 12:CD012173. 10.1002/14651858.CD012173.pub2
10.
Zurück zum Zitat Phillips JS, Westerberg B (2011) Intratympanic steroids for Meniere's disease or syndrome. Cochrane Database Syst Rev 7:CD008514. 10.1002/14651858.CD008514.pub2 Phillips JS, Westerberg B (2011) Intratympanic steroids for Meniere's disease or syndrome. Cochrane Database Syst Rev 7:CD008514. 10.1002/14651858.CD008514.pub2
11.
Zurück zum Zitat Pullens B, van Benthem PP (2011) Intratympanic gentamicin for Meniere's disease or syndrome. Cochrane Database Syst Rev 3:CD008234. 10.1002/14651858.CD008234.pub2 Pullens B, van Benthem PP (2011) Intratympanic gentamicin for Meniere's disease or syndrome. Cochrane Database Syst Rev 3:CD008234. 10.1002/14651858.CD008234.pub2
13.
Zurück zum Zitat Leong SC, Narayan S, Lesser TH (2013) Antisecretory factor-inducing therapy improves patient-reported functional levels in Meniere's disease. Ann Otol Rhinol Laryngol 122(10):619–624CrossRef Leong SC, Narayan S, Lesser TH (2013) Antisecretory factor-inducing therapy improves patient-reported functional levels in Meniere's disease. Ann Otol Rhinol Laryngol 122(10):619–624CrossRef
20.
Zurück zum Zitat Laurenius A, Wangberg B, Lange S, Jennische E, Lundgren BK, Bosaeus I (2003) Antisecretory factor counteracts secretory diarrhoea of endocrine origin. Clin Nutr 22(6):549–552CrossRef Laurenius A, Wangberg B, Lange S, Jennische E, Lundgren BK, Bosaeus I (2003) Antisecretory factor counteracts secretory diarrhoea of endocrine origin. Clin Nutr 22(6):549–552CrossRef
21.
Zurück zum Zitat Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease (1995) American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 113(3):181–185. 10.1016/S0194-5998(95)70102-8 Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease (1995) American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 113(3):181–185. 10.1016/S0194-5998(95)70102-8
22.
Zurück zum Zitat Newman CW, Weinstein BE, Jacobson GP, Hug GA (1990) The Hearing Handicap Inventory for adults: psychometric adequacy and audiometric correlates. Ear Hear 11(6):430–433CrossRef Newman CW, Weinstein BE, Jacobson GP, Hug GA (1990) The Hearing Handicap Inventory for adults: psychometric adequacy and audiometric correlates. Ear Hear 11(6):430–433CrossRef
23.
Zurück zum Zitat Passi S, Ralli G, Capparelli E, Mammone A, Scacciatelli D, Cianfrone G (2008) The THI questionnaire: psychometric data for reliability and validity of the Italian version. Int Tinnitus J 14(1):26–33PubMed Passi S, Ralli G, Capparelli E, Mammone A, Scacciatelli D, Cianfrone G (2008) The THI questionnaire: psychometric data for reliability and validity of the Italian version. Int Tinnitus J 14(1):26–33PubMed
Metadaten
Titel
Food-induced stimulation of the antisecretory factor to improve symptoms in Meniere’s disease: our results
verfasst von
Alfonso Scarpa
Massimo Ralli
Pasquale Viola
Claudia Cassandro
Matteo Alicandri-Ciufelli
Maurizio Iengo
Giuseppe Chiarella
Marco de Vincentiis
Michele Cavaliere
Ettore Cassandro
Publikationsdatum
11.10.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 1/2020
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-019-05682-4

Weitere Artikel der Ausgabe 1/2020

European Archives of Oto-Rhino-Laryngology 1/2020 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.